CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sept. 1, 2006--Idera Pharmaceuticals, Inc. (AMEX: IDP) today announced that Robert Karr, M.D., President of Idera, will discuss the Company's TLR-targeted drug discovery and development programs and provide a general corporate overview during presentations at the following investor conferences:
